Health Care • Biotechnology: Laboratory Analytical Instruments
$449.53 ▼ -13.19
(-2.85%)
MKT CAP: $45.46B • VOL: 1.94M
52W L $283 52W H $482
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$378
MEDIAN
$503
MEAN
$512
HIGH
$611
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE WAT TAPE
WAT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $543.93 | $516.96 | 2025-02-14 | $409.07 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $566.41 | $530.45 | 2025-02-06 | $422.56 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $512.46 | $494.48 | 2025-01-29 | $431.55 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $458.52 | — | 2025-01-17 | $440.54 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $395.59 | $427.05 | 2025-01-09 | $400.08 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $534.94 | $467.51 | 2024-12-18 | $391.09 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $436.04 | $454.03 | 2024-12-04 | $418.06 | -4.3% | 48% | C |